Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Intestinal ex vivo organoid culture reveals altered programmed crypt stem cells in patients with celiac disease.

Dieterich W, Neurath MF, Zopf Y.

Sci Rep. 2020 Feb 26;10(1):3535. doi: 10.1038/s41598-020-60521-5.

2.

Assessing cachexia in older patients: Different definitions - But which one is the most practical for clinical routine?

Zopf Y, Schink K, Reljic D, Herrmann HJ, Dieterich W, Kiesswetter E, Sieber CC, Neurath MF, Volkert D.

Arch Gerontol Geriatr. 2020 Jan - Feb;86:103943. doi: 10.1016/j.archger.2019.103943. Epub 2019 Sep 6.

PMID:
31561063
3.

Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary?

Dieterich W, Zopf Y.

Nutrients. 2019 Aug 20;11(8). pii: E1957. doi: 10.3390/nu11081957.

4.

Microbiota in the Gastrointestinal Tract.

Dieterich W, Schink M, Zopf Y.

Med Sci (Basel). 2018 Dec 14;6(4). pii: E116. doi: 10.3390/medsci6040116. Review.

5.

Dietary Effects on Microbiota-New Trends with Gluten-Free or Paleo Diet.

Zopf Y, Reljic D, Dieterich W.

Med Sci (Basel). 2018 Oct 18;6(4). pii: E92. doi: 10.3390/medsci6040092. Review.

6.

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.

Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, Hildner K, Waldner MJ, Mudter J, Hartmann A, Grützmann R, Neufert C, Münster T, Neurath MF, Atreya R.

Gut. 2019 May;68(5):814-828. doi: 10.1136/gutjnl-2017-315671. Epub 2018 May 30.

7.

Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity.

Dieterich W, Schuppan D, Schink M, Schwappacher R, Wirtz S, Agaimy A, Neurath MF, Zopf Y.

Clin Nutr. 2019 Apr;38(2):697-707. doi: 10.1016/j.clnu.2018.03.017. Epub 2018 Apr 4.

PMID:
29653862
8.

The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update.

Catassi C, Alaedini A, Bojarski C, Bonaz B, Bouma G, Carroccio A, Castillejo G, De Magistris L, Dieterich W, Di Liberto D, Elli L, Fasano A, Hadjivassiliou M, Kurien M, Lionetti E, Mulder CJ, Rostami K, Sapone A, Scherf K, Schuppan D, Trott N, Volta U, Zevallos V, Zopf Y, Sanders DS.

Nutrients. 2017 Nov 21;9(11). pii: E1268. doi: 10.3390/nu9111268. Review.

9.

Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.

Billmeier U, Dieterich W, Neurath MF, Atreya R.

World J Gastroenterol. 2016 Nov 14;22(42):9300-9313. Review.

10.

In situ enzymatic activity of transglutaminase isoforms on brain tissue sections of rodents: A new approach to monitor differences in post-translational protein modifications during neurodegeneration.

Schulze-Krebs A, Canneva F, Schnepf R, Dobner J, Dieterich W, von Hörsten S.

Brain Res. 2016 Jan 15;1631:22-33. doi: 10.1016/j.brainres.2015.11.027. Epub 2015 Nov 23.

PMID:
26616340
11.

[Non-celiac disease non-wheat allergy wheat sensitivity].

Zopf Y, Dieterich W.

Dtsch Med Wochenschr. 2015 Nov;140(22):1683-7. doi: 10.1055/s-0041-106311. Epub 2015 Nov 4. Review. German.

PMID:
26536646
12.

Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria.

Catassi C, Elli L, Bonaz B, Bouma G, Carroccio A, Castillejo G, Cellier C, Cristofori F, de Magistris L, Dolinsek J, Dieterich W, Francavilla R, Hadjivassiliou M, Holtmeier W, Körner U, Leffler DA, Lundin KE, Mazzarella G, Mulder CJ, Pellegrini N, Rostami K, Sanders D, Skodje GI, Schuppan D, Ullrich R, Volta U, Williams M, Zevallos VF, Zopf Y, Fasano A.

Nutrients. 2015 Jun 18;7(6):4966-77. doi: 10.3390/nu7064966.

13.

Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.

Popov Y, Sverdlov DY, Sharma AK, Bhaskar KR, Li S, Freitag TL, Lee J, Dieterich W, Melino G, Schuppan D.

Gastroenterology. 2011 May;140(5):1642-52. doi: 10.1053/j.gastro.2011.01.040. Epub 2011 Jan 26.

14.

Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42.

Ruehl M, Muche M, Freise C, Erben U, Neumann U, Schuppan D, Popov Y, Dieterich W, Zeitz M, Farndale RW, Somasundaram R.

Fibrogenesis Tissue Repair. 2011 Jan 6;4(1):1. doi: 10.1186/1755-1536-4-1.

15.

Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.

Zöller-Utz IM, Esslinger B, Schulze-Krebs A, Dieterich W.

J Clin Immunol. 2010 Mar;30(2):204-12. doi: 10.1007/s10875-009-9347-z. Epub 2009 Nov 27.

PMID:
19943187
16.

In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease.

Rakhimova M, Esslinger B, Schulze-Krebs A, Hahn EG, Schuppan D, Dieterich W.

J Clin Immunol. 2009 Jan;29(1):29-37. doi: 10.1007/s10875-008-9228-x. Epub 2008 Aug 12.

PMID:
18696220
17.

The elongated first fibronectin type III domain of collagen XIV is an inducer of quiescence and differentiation in fibroblasts and preadipocytes.

Ruehl M, Erben U, Schuppan D, Wagner C, Zeller A, Freise C, Al-Hasani H, Loesekann M, Notter M, Wittig BM, Zeitz M, Dieterich W, Somasundaram R.

J Biol Chem. 2005 Nov 18;280(46):38537-43. Epub 2005 Aug 29.

18.

Pathomechanisms in celiac disease.

Dieterich W, Esslinger B, Schuppan D.

Int Arch Allergy Immunol. 2003 Oct;132(2):98-108. Review.

PMID:
14600421
19.

Innate immunity and coeliac disease.

Schuppan D, Esslinger B, Dieterich W.

Lancet. 2003 Jul 5;362(9377):3-4. No abstract available.

PMID:
12853189
20.

A molecular warhead and its target: tissue transglutaminase and Celiac Sprue.

Schuppan D, Dieterich W.

Chem Biol. 2003 Mar;10(3):199-201.

PMID:
12670530

Supplemental Content

Loading ...
Support Center